Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00050973

Public ClinicalTrials.gov record NCT00050973. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 10:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Phase III Trial Comparing Targretin Capsules/Cisplatin/Vinorelbine Versus Cisplatin/Vinorelbine in Chemotherapy-Naive Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Study identification

NCT ID
NCT00050973
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eisai Inc.
Industry
Enrollment
623 participants

Conditions and interventions

Interventions

  • bexarotene Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Oct 31, 2004
Completion
Feb 28, 2005
Last update posted
May 13, 2013

Ends 2005

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Brookwood Medical Center Birmingham Alabama 35209
Southern Arizona VA Healthcare System Tucson Arizona 85723
Arroyo Research Inc. Pasadena California 91105
Desert Hematology-Oncology Medical Group, Inc. Rancho Mirage California 92270
University of Florida Gainsville Florida 32610
New Hope Cancer Center Hudson Florida 34667
Veterans Affairs Medical Center Miami Florida 33125
Bay Area Cancer Consultants Palm Harbor Florida 34684
Northwest Medical Specialists Arlington Heights Illinois 60004
Jayne Gurtler, M.D., APMC Metairie Louisiana 70006
Louisiana State University Health Science Center New Orleans Louisiana 70112
St. Joseph Mercy Oakland Hospital Pontiac Michigan 48341
Capitol Comprehensive Cancer Care Clinic Jefferson City Missouri 65109
SUNY Downstate Medical Center Brooklyn New York 11203
VA Western New York Health Care System Buffalo New York 14215
Hematology-Oncology Associates Toledo Ohio 43623
Tariq Mahmood Midwest City Oklahoma 73110
University Oncology & Hematology Associates Chattanooga Tennessee 37404
Marshfield Medical Research Foundation Marshfield Wisconsin 54449
Medical Associates Health Centers Menomonee Falls Wisconsin 53051

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00050973, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2013 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00050973 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →